$2.28
-0.18-7.32%
At close: -
$2.28
0.000.00%
After Hours: 4:00 PM EDT
Macrogenics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Macrogenics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $0.90 | $0.21 | 328.6 % |
Q2 | 2024-08-06 | $-0.89 | $-0.59 | -50.8 % |
Q1 | 2024-05-09 | $-0.84 | $-0.64 | -31.3 % |
Q4 | 2024-03-07 | $-0.75 | $-0.15 | -400.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $110.71M | $76.11M | 45.5 % |
Q2 | 2024-08-06 | $10.80M | $21.24M | -49.2 % |
Q1 | 2024-05-09 | $9.10M | $14.62M | -37.7 % |
Q3 | 2023-11-06 | $10.40M | $48.86M | -78.7 % |
Macrogenics (MGNX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
The Actual EPS was $0.90, which beat the estimate of $0.21.
The Actual Revenue was $110.7M, which beat the estimate of $76.1M.
Browse earnings estimates, EPS, and revenue on all stocks.